Recent MSK Discoveries & Advances

Our Research Impact
Paul Marks Prize for Cancer Research
Recent MSK Discoveries & Advances
Research Awards & Honors
Researcher Interviews
Emeritus Faculty

Recent MSK Discoveries & Advances

Share
Share

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
375 News Items found
Q&A
Pictured: Ming Li
Study Suggests New Ways of Manipulating Immune System to Treat Autoimmune Diseases and Cancer

Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.
In the Lab
Pictured: PET Scan
New Imaging Agent Could Improve Prostate Cancer Diagnosis and Treatment

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.
In the Lab
Pictured: Structure of Synthesized Erythropoietin
Memorial Sloan Kettering Investigators Synthesize Vital Biological Molecule Erythropoietin for the First Time

Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.
Snapshot
Pictured: Tunneling Nanotubes
Tunneling Nanotubes Connect Cancer Cells

Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.
In the Lab
Pictured: Ross Levine
Researchers Discover Why Some Leukemia Drugs Are Not Sufficiently Effective

Memorial Sloan Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms.
In the Lab
Pictured: Natural Killer Cells & Cancer Cell
Study Suggests Refined Donor Selection Could Improve Outcomes of Bone Marrow Transplantation in Leukemia

In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.
In the Lab
Pictured: Filippo Giancotti
Researchers Shed Light on Why Some Breast Cancers Spread to the Lungs

A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.
In the Clinic
Pictured: Isabelle Rivière and Michel Sadelain
Launch of Stem Cell Therapy Trial Offers Hope for Patients with Inherited Blood Disorder

Memorial Sloan Kettering’s trial to evaluate a new therapy for patients with beta-thalassemia is the first to receive FDA approval to treat this disease with genetically engineered cells.
In the Lab
Pictured: Joan Massagué
Study Links Cancer’s Ability to Spread with Chemotherapy Resistance

A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
In the Lab
Pictured: Douglas Levine and Petar Jelinic
New Web Tool Helps Researchers Explore How the Genome Changes in Cancer

Memorial Sloan Kettering investigators hope their new web tool will improve the accessibility of large-scale genome-sequencing information for cancer researchers everywhere, and accelerate research and therapeutic discovery.